About this trial
The goal of this study is to compare the level of engagement in the Hispanic and Latino parents of autistic children and culturally adapt the protocol of Ayres Sensory Integration to improve participation and health outcomes.
The main questions it aims to answer are:
Does the Design Thinking process result in higher stakeholder engagement and satisfaction in the research process in comparison to Focus Groups? Secondary question: Do cultural adaption using DT data yield higher scores of acceptability and implementation feasibility in comparison to FG methods?
Participants will:
* Be randomized into two groups of engagement (focus groups and design thinking) * Be blinded (clinicians, selected caregivers, autistic persons, and cultural experts) and will rate the acceptability, feasibility, and cultural appropriateness of the protocol based on DT data higher than the protocol based on FG data.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
confirmed diagnosis of autism spectrum disorder
Hispanic/Latino
received therapeutic services as a child; and
willing and able (with i.e., language and cognitive skills) to participate in the design thinking or focus group session designed to learn about the facilitator and barriers to receipt of therapeutic services.
Disqualifiers
Do not meet age for autistic individual or diagnostic criteria
Trial design
Parallel
Treatments tested in this trial
Design Thinking
Other interventionParticipants attend the DT session through all the stages that include emphasize, define, ideate, prototype and test.
Focus Groups
Other interventionParticipants attend the FG that includes the introduction. discussion, and reflection.
Treatment groups
Trial outcomes
Primary outcomes
Stakeholder-Centric Engagement Evaluation
The instrument evaluates stakeholder engagement via the PCORI engagement principles. DT and FG participants use this instrument to rate engagement in throughout the research process using a Likert scale with 1= never and 5 = always.
Secondary outcomes
Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM) and the Feasibility of Intervention Measure (FIM) (Weiner et al., 2017)
These are outcome measures that evaluate implementation success via the extent to which stakeholders believe the intervention is acceptable, appropriate, and feasible. Each measure uses a Likert response scale where 1 = completely disagree and 5 = completely agree.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Thomas Jefferson University
Lead sponsor
Patient-Centered Outcomes Research Institute
Collaborator
This trial is not recruiting at the moment. You can still explore other options: